Eli Lilly shares could remain under the microscope on Wednesday after falling sharply Tuesday as the pharmaceutical giant lowered its 2024 full-year forecast. Monitor these key price levels.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback